Total Payments
$1,424
2020 Payments
$380.86
Companies
13
Transactions
24
Medicare Patients
731
Medicare Billing
$90,606
Payment Breakdown by Category
Consulting$800.00 (56.2%)
Food & Beverage$491.34 (34.5%)
Education$132.99 (9.3%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $800.00 | 1 | 56.2% |
| Food and Beverage | $491.34 | 19 | 34.5% |
| Education | $132.99 | 4 | 9.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Bayer HealthCare Pharmaceuticals Inc. | $820.54 | 2 | $0 (2020) |
| E.R. Squibb & Sons, L.L.C. | $246.99 | 5 | $0 (2020) |
| Astellas Pharma US Inc | $111.82 | 2 | $0 (2020) |
| PFIZER INC. | $56.38 | 4 | $0 (2020) |
| Lilly USA, LLC | $33.34 | 2 | $0 (2020) |
| Amgen Inc. | $26.63 | 2 | $0 (2018) |
| Dova Pharmaceuticals | $22.22 | 1 | $0 (2020) |
| Celgene Corporation | $21.85 | 1 | $0 (2020) |
| GENZYME CORPORATION | $19.20 | 1 | $0 (2020) |
| Seagen Inc. | $18.44 | 1 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2020 | $380.86 | 18 | Astellas Pharma US Inc ($111.82) |
| 2019 | $110.76 | 1 | E.R. Squibb & Sons, L.L.C. ($110.76) |
| 2018 | $916.99 | 4 | Bayer HealthCare Pharmaceuticals Inc. ($800.00) |
| 2017 | $15.72 | 1 | Amgen Inc. ($15.72) |
All Payment Transactions
24 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 08/14/2020 | Astellas Pharma US Inc | — | Education | In-kind items and services | $95.00 | General |
| 03/13/2020 | GENZYME CORPORATION | ELITEK (Biological), SARCLISA | Food and Beverage | In-kind items and services | $19.20 | General |
| Category: Oncology | ||||||
| 03/11/2020 | PFIZER INC. | BOSULIF (Drug), DAURISMO, RUXIENCE | Food and Beverage | In-kind items and services | $18.39 | General |
| Category: METABOLIC DISEASE;ONCOLOGY | ||||||
| 03/05/2020 | Bayer HealthCare Pharmaceuticals Inc. | Nubeqa (Drug), Xofigo | Food and Beverage | In-kind items and services | $20.54 | General |
| Category: Oncology | ||||||
| 02/27/2020 | E.R. Squibb & Sons, L.L.C. | OPDIVO (Biological) | Food and Beverage | Cash or cash equivalent | $13.72 | General |
| Category: Oncology | ||||||
| 02/24/2020 | AstraZeneca Pharmaceuticals LP | IMFINZI (Drug) | Food and Beverage | In-kind items and services | $11.71 | General |
| Category: Oncology | ||||||
| 02/20/2020 | Dova Pharmaceuticals | Doptelet (Drug) | Food and Beverage | In-kind items and services | $22.22 | General |
| Category: Hematology/Oncology | ||||||
| 02/19/2020 | Pharmacyclics LLC, An AbbVie Company | Imbruvica (Drug) | Food and Beverage | In-kind items and services | $17.94 | General |
| Category: Oncology | ||||||
| 02/15/2020 | Lilly USA, LLC | CYRAMZA (Drug), VERZENIO | Food and Beverage | In-kind items and services | $14.24 | General |
| Category: Oncology | ||||||
| 02/07/2020 | Seagen Inc. | ADCETRIS (Biological) | Food and Beverage | In-kind items and services | $18.44 | General |
| Category: Oncology | ||||||
| 02/03/2020 | Celgene Corporation | INREBIC (Drug) | Food and Beverage | Cash or cash equivalent | $21.85 | General |
| Category: Hematology | ||||||
| 01/27/2020 | PFIZER INC. | XALKORI (Drug) | Education | In-kind items and services | $13.90 | General |
| Category: ONCOLOGY | ||||||
| 01/27/2020 | PFIZER INC. | BRAFTOVI (Drug), MEKTOVI | Education | In-kind items and services | $13.04 | General |
| Category: ONCOLOGY | ||||||
| 01/27/2020 | PFIZER INC. | LORBRENA (Drug) | Education | In-kind items and services | $11.05 | General |
| Category: ONCOLOGY | ||||||
| 01/24/2020 | E.R. Squibb & Sons, L.L.C. | OPDIVO (Biological) | Food and Beverage | Cash or cash equivalent | $16.43 | General |
| Category: Oncology | ||||||
| 01/16/2020 | Lilly USA, LLC | ALIMTA (Drug), CYRAMZA, VERZENIO | Food and Beverage | In-kind items and services | $19.10 | General |
| Category: Oncology | ||||||
| 01/08/2020 | Ipsen Biopharmaceuticals, Inc | SOMATULINE DEPOT (Drug), ONIVYDE | Food and Beverage | In-kind items and services | $17.27 | General |
| Category: Oncology/Endocrinology | ||||||
| 01/07/2020 | Astellas Pharma US Inc | XTANDI (Drug) | Food and Beverage | In-kind items and services | $16.82 | General |
| Category: ONCOLOGY | ||||||
| 01/17/2019 | E.R. Squibb & Sons, L.L.C. | EMPLICITI (Biological) | Food and Beverage | Cash or cash equivalent | $110.76 | General |
| Category: Oncology | ||||||
| 05/17/2018 | E.R. Squibb & Sons, L.L.C. | OPDIVO (Biological) | Food and Beverage | Cash or cash equivalent | $96.10 | General |
| Category: Oncology | ||||||
| 05/14/2018 | Amgen Inc. | Kyprolis (Biological), XGEVA | Food and Beverage | In-kind items and services | $10.91 | General |
| Category: Oncology | ||||||
| 03/05/2018 | E.R. Squibb & Sons, L.L.C. | OPDIVO (Biological) | Food and Beverage | Cash or cash equivalent | $9.98 | General |
| Category: Oncology | ||||||
| 01/18/2018 | Bayer HealthCare Pharmaceuticals Inc. | Aliqopa (Drug) | Consulting Fee | Cash or cash equivalent | $800.00 | General |
| Category: Oncology | ||||||
| 12/06/2017 | Amgen Inc. | Neulasta (Biological) | Food and Beverage | In-kind items and services | $15.72 | General |
| Category: Oncology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 145 | 234 | $63,028 | $15,861 |
| 2022 | 3 | 115 | 131 | $38,417 | $9,891 |
| 2021 | 7 | 230 | 23,558 | $161,131 | $43,139 |
| 2020 | 3 | 241 | 322 | $57,689 | $21,715 |
Total Patients
731
Total Services
24,245
Medicare Billing
$90,606
Procedure Codes
22
All Medicare Procedures & Services
22 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 41 | 90 | $24,965 | $6,510 | 26.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 68 | 108 | $20,948 | $4,743 | 22.6% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2023 | 36 | 36 | $17,115 | $4,608 | 26.9% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2022 | 32 | 32 | $15,316 | $4,200 | 27.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 37 | 48 | $13,200 | $3,209 | 24.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2022 | 46 | 51 | $9,901 | $2,482 | 25.1% |
| J1439 | Injection, ferric carboxymaltose, 1 mg | Office | 2021 | 20 | 23,250 | $93,000 | $20,927 | 22.5% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 25 | 74 | $17,390 | $6,514 | 37.5% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Facility | 2021 | 37 | 37 | $18,648 | $5,421 | 29.1% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 33 | 53 | $8,268 | $3,223 | 39.0% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 16 | 26 | $6,812 | $2,055 | 30.2% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Office | 2021 | 13 | 13 | $6,370 | $1,938 | 30.4% |
| 96365 | Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour | Office | 2021 | 18 | 26 | $4,680 | $1,409 | 30.1% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Facility | 2021 | 23 | 25 | $4,425 | $1,337 | 30.2% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2021 | 25 | 32 | $1,120 | $248.64 | 22.2% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2021 | 20 | 22 | $418.00 | $66.00 | 15.8% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Facility | 2020 | 100 | 137 | $19,865 | $7,892 | 39.7% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 18 | 51 | $11,985 | $4,318 | 36.0% |
| 99205 | New patient office or other outpatient visit, typically 60 minutes | Facility | 2020 | 29 | 29 | $8,961 | $3,869 | 43.2% |
| 99205 | New patient office or other outpatient visit, typically 60 minutes | Office | 2020 | 13 | 13 | $6,370 | $2,107 | 33.1% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Facility | 2020 | 61 | 61 | $5,734 | $1,840 | 32.1% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 20 | 31 | $4,774 | $1,690 | 35.4% |
About Dr. Steven Akman, MD
Dr. Steven Akman, MD is a Hematology & Oncology healthcare provider based in Charleston, South Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/01/2005. The National Provider Identifier (NPI) number assigned to this provider is 1396729414.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Steven Akman, MD has received a total of $1,424 in payments from pharmaceutical and medical device companies, with $380.86 received in 2020. These payments were reported across 24 transactions from 13 companies. The most common payment nature is "Consulting Fee" ($800.00).
As a Medicare-enrolled provider, Akman has provided services to 731 Medicare beneficiaries, totaling 24,245 services with total Medicare billing of $90,606. Data is available for 4 years (2020–2023), covering 22 distinct procedure/service records.
Ad
Practice Information
- Specialty Hematology & Oncology
- Other Specialties Medical Oncology, Medical Oncology
- Location Charleston, SC
- Active Since 12/01/2005
- Last Updated 12/15/2023
- Taxonomy Code 207RH0003X
- Entity Type Individual
- NPI Number 1396729414
Products in Payments
- Aliqopa (Drug) $800.00
- OPDIVO (Biological) $136.23
- EMPLICITI (Biological) $110.76
- Doptelet (Drug) $22.22
- INREBIC (Drug) $21.85
- Nubeqa (Drug) $20.54
- ELITEK (Biological) $19.20
- ALIMTA (Drug) $19.10
- ADCETRIS (Biological) $18.44
- BOSULIF (Drug) $18.39
- Imbruvica (Drug) $17.94
- SOMATULINE DEPOT (Drug) $17.27
- XTANDI (Drug) $16.82
- Neulasta (Biological) $15.72
- CYRAMZA (Drug) $14.24
- XALKORI (Drug) $13.90
- BRAFTOVI (Drug) $13.04
- IMFINZI (Drug) $11.71
- LORBRENA (Drug) $11.05
- Kyprolis (Biological) $10.91
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Hematology & Oncology Doctors in Charleston
Mr. George Geils, M.d, M.D
Hematology & Oncology — Payments: $184,021
Hematology & Oncology $184,021
Mr. David Ellison, M.d, M.D
Hematology & Oncology — Payments: $39,035
Hematology & Oncology $39,035
Dr. Albert Lockhart, Md, MD
Hematology & Oncology — Payments: $36,997
Hematology & Oncology $36,997
Dr. Irl Greenwell, M.d, M.D
Hematology & Oncology — Payments: $30,803
Hematology & Oncology $30,803
Dr. Brian Lingerfelt, Md, MD
Hematology & Oncology — Payments: $30,721
Hematology & Oncology $30,721
Robert Stuart, Md, MD
Hematology & Oncology — Payments: $25,933
Hematology & Oncology $25,933